Sac-TMT Combined With Fruquintinib as Second-Line Treatment in Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Clinical trial NCT07689292 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07689292
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Gastroesophageal Junction (GEJ) Adenocarcinoma Gastro-esophageal Junction Adenocarcinoma

Start date: 2026-07-31
Primary completion: 2027-08-31
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.